N-[6-[1-[(2,6-dimethoxyphenyl)methyl]piperidin-4-yl]pyrazin-2-yl]-4,6-dimethylpyrimidin-2-amine
C24H30N6O2 — CID 110094212
Data last refreshed: (MolForge compound catalog, from PubChem)
About N-[6-[1-[(2,6-dimethoxyphenyl)methyl]piperidin-4-yl]pyrazin-2-yl]-4,6-dimethylpyrimidin-2-amine
N-[6-[1-[(2,6-dimethoxyphenyl)methyl]piperidin-4-yl]pyrazin-2-yl]-4,6-dimethylpyrimidin-2-amine (PubChem CID 110094212) has the molecular formula C24H30N6O2 and a molecular weight of 434.54 g/mol. Its IUPAC name is N-[6-[1-[(2,6-dimethoxyphenyl)methyl]piperidin-4-yl]pyrazin-2-yl]-4,6-dimethylpyrimidin-2-amine.
Molecular Properties
| Compound Name | N-[6-[1-[(2,6-dimethoxyphenyl)methyl]piperidin-4-yl]pyrazin-2-yl]-4,6-dimethylpyrimidin-2-amine |
|---|---|
| PubChem CID | 110094212 |
| Molecular Formula | C24H30N6O2 |
| Molecular Weight | 434.54 g/mol |
| Exact Mass | 434.24 |
| IUPAC Name | N-[6-[1-[(2,6-dimethoxyphenyl)methyl]piperidin-4-yl]pyrazin-2-yl]-4,6-dimethylpyrimidin-2-amine |
| SMILES | COc1cccc(OC)c1CN1CCC(c2cncc(Nc3nc(C)cc(C)n3)n2)CC1 |
| InChI | InChI=1S/C24H30N6O2/c1-16-12-17(2)27-24(26-16)29-23-14-25-13-20(28-23)18-8-10-30(11-9-18)15-19-21(31-3)6-5-7-22(19)32-4/h5-7,12-14,18H,8-11,15H2,1-4H3,(H,26,27,28,29) |
| InChIKey | SOFBPXPRCCUNHO-UHFFFAOYSA-N |
| XLogP | 4.02 |
| TPSA | 85.29 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 32 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 434.54 |
| LogP ≤ 5 | 4.02 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 8 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 110094212 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.